BIOMAT Database Logo BIOMAT Database Logo

Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease. 2017

Emre Menteşe, and Hakan Bektaş, and Bahar Bilgin Sokmen, and Mustafa Emirik, and Demet Çakır, and Bahittin Kahveci
Department of Chemistry, Art and Science Faculty, Recep Tayyip Erdogan University, Rize, Turkey. Electronic address: emre.mentese@erdogan.edu.tr.

A new series of benzimidazole compounds including hydrazinecarbothioamide, 1,2,4-triazole, 1,3,4-oxadiazole and imine function were synthesized starting from 5,6-dichloro-2-cyclopropyl-1H-benzimidazole. All of the benzimidazole derivatives exhibited good urease inhibitor activity. Compound 6a proved to be the most potent showing an enzyme inhibitory activity with an IC50=0.06µM. Molecular docking studies were also conducted on enzyme extracted from Jack bean urease to identify the binding mode of the newly synthesized compounds.

UI MeSH Term Description Entries
D007097 Imines Organic compounds containing a carbon-nitrogen double bond where a NITROGEN atom can be attached to HYDROGEN or an alkyl or aryl group. Imine
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D014510 Urease An enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5. Phytourease,Urea Amidohydrolase,Amidohydrolase, Urea
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Emre Menteşe, and Hakan Bektaş, and Bahar Bilgin Sokmen, and Mustafa Emirik, and Demet Çakır, and Bahittin Kahveci
Design, molecular docking and synthesis of novel 5,6-dichloro-2-methyl-1H-benzimidazole derivatives as potential urease enzyme inhibitors.
May 2019, Bioorganic chemistry,
Emre Menteşe, and Hakan Bektaş, and Bahar Bilgin Sokmen, and Mustafa Emirik, and Demet Çakır, and Bahittin Kahveci
Novel benzimidazole derivatives; synthesis, bioactivity and molecular docking study as potent urease inhibitors.
June 2022, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences,
Emre Menteşe, and Hakan Bektaş, and Bahar Bilgin Sokmen, and Mustafa Emirik, and Demet Çakır, and Bahittin Kahveci
New benzimidazole-oxadiazole derivatives as potent VEGFR-2 inhibitors: Synthesis, anticancer evaluation, and docking study.
June 2024, Drug development research,
Emre Menteşe, and Hakan Bektaş, and Bahar Bilgin Sokmen, and Mustafa Emirik, and Demet Çakır, and Bahittin Kahveci
Synthesis and molecular docking study of piperazine derivatives as potent urease inhibitors.
August 2018, Bioorganic chemistry,
Emre Menteşe, and Hakan Bektaş, and Bahar Bilgin Sokmen, and Mustafa Emirik, and Demet Çakır, and Bahittin Kahveci
Synthesis, molecular docking and biological evaluation of some benzimidazole derivatives as potent pancreatic lipase inhibitors.
February 2018, Bioorganic chemistry,
Emre Menteşe, and Hakan Bektaş, and Bahar Bilgin Sokmen, and Mustafa Emirik, and Demet Çakır, and Bahittin Kahveci
New Triazinoindole Bearing Benzimidazole/Benzoxazole Hybrids Analogs as Potent Inhibitors of Urease: Synthesis, In Vitro Analysis and Molecular Docking Studies.
October 2022, Molecules (Basel, Switzerland),
Emre Menteşe, and Hakan Bektaş, and Bahar Bilgin Sokmen, and Mustafa Emirik, and Demet Çakır, and Bahittin Kahveci
Novel flurbiprofen clubbed oxadiazole derivatives as potential urease inhibitors and their molecular docking study.
August 2023, RSC advances,
Emre Menteşe, and Hakan Bektaş, and Bahar Bilgin Sokmen, and Mustafa Emirik, and Demet Çakır, and Bahittin Kahveci
Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
October 2022, Molecules (Basel, Switzerland),
Emre Menteşe, and Hakan Bektaş, and Bahar Bilgin Sokmen, and Mustafa Emirik, and Demet Çakır, and Bahittin Kahveci
Synthesis of Some Benzimidazole Derivatives Bearing 1,3,4-Oxadiazole Moiety as Anticancer Agents.
April 2015, Chemical science transactions,
Emre Menteşe, and Hakan Bektaş, and Bahar Bilgin Sokmen, and Mustafa Emirik, and Demet Çakır, and Bahittin Kahveci
Synthesis of new isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study.
November 2019, Scientific reports,
Copied contents to your clipboard!